Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Brinkmann

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Novartis Foundation Symposium|May 7, 2002
Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivoUlrich Brinkmann
Trends in Molecular Medicine|December 14, 2023
Diphthamide - a conserved modification of eEF2 with clinical relevanceRaffael Schaffrath, Ulrich Brinkmann
Drug Discovery Today|March 3, 2015
Bispecific antibodiesRoland E Kontermann, Ulrich Brinkmann
Mabs|January 16, 2026
The making of multispecific immunoglobulins - a clinical perspectiveUlrich Brinkmann, Roland E Kontermann
Mabs|January 11, 2017
The making of bispecific antibodiesUlrich Brinkmann, Roland E Kontermann
Immunological Reviews|February 12, 2016
Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload deliveryStefan Dengl, Claudio Sustmann, Ulrich Brinkmann
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2012
Generation of fluorescent IgG fusion proteins in mammalian cellsAlexander K Haas, Klaus Mayer, Ulrich Brinkmann
Computational and Structural Biotechnology Journal|June 17, 2020
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodiesSteffen Dickopf, Guy J Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|May 18, 2012
Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizonUlrich H Weidle, Guy Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|August 30, 2020
microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Ulrich Brinkmann, Simon Auslaender
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Novartis Foundation Symposium|May 7, 2002
Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivoUlrich Brinkmann
Trends in Molecular Medicine|December 14, 2023
Diphthamide - a conserved modification of eEF2 with clinical relevanceRaffael Schaffrath, Ulrich Brinkmann
Drug Discovery Today|March 3, 2015
Bispecific antibodiesRoland E Kontermann, Ulrich Brinkmann
Mabs|January 16, 2026
The making of multispecific immunoglobulins - a clinical perspectiveUlrich Brinkmann, Roland E Kontermann
Mabs|January 11, 2017
The making of bispecific antibodiesUlrich Brinkmann, Roland E Kontermann
Immunological Reviews|February 12, 2016
Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload deliveryStefan Dengl, Claudio Sustmann, Ulrich Brinkmann
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2012
Generation of fluorescent IgG fusion proteins in mammalian cellsAlexander K Haas, Klaus Mayer, Ulrich Brinkmann
Computational and Structural Biotechnology Journal|June 17, 2020
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodiesSteffen Dickopf, Guy J Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|May 18, 2012
Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizonUlrich H Weidle, Guy Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|August 30, 2020
microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Ulrich Brinkmann, Simon Auslaender
Pageof 10